Bogart Wealth’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $48.6K | Sell |
215
-5
| -2% | -$1.06K | ﹤0.01% | 565 |
|
|
2026
Q2 | $47.5K | Buy |
220
+5
| +2% | +$956 | ﹤0.01% | 550 |
|
|
2026
Q1 | $39.4K | Sell |
215
-294
| -58% | -$54.2K | ﹤0.01% | 554 |
|
|
2025
Q4 | $89.6K | Buy |
509
+196
| +63% | +$32K | ﹤0.01% | 354 |
|
|
2025
Q3 | $43.8K | Buy |
313
+104
| +50% | +$14.1K | ﹤0.01% | 490 |
|
|
2025
Q2 | $26.2K | Hold |
209
| – | – | ﹤0.01% | 575 |
|
|
2025
Q1 | $28.6K | Hold |
209
| – | – | ﹤0.01% | 511 |
|
|
2024
Q4 | $32K | Hold |
209
| – | – | ﹤0.01% | 491 |
|
|
2024
Q3 | $40.5K | Hold |
209
| – | – | ﹤0.01% | 450 |
|
|
2024
Q2 | $48.4K | Sell |
209
-8
| -4% | -$1.74K | ﹤0.01% | 414 |
|
|
2024
Q1 | $46.8K | Sell |
217
-11
| -5% | -$2.58K | ﹤0.01% | 394 |
|
|
2023
Q4 | $59K | Hold |
228
| – | – | ﹤0.01% | 349 |
|
|
2023
Q3 | $58.6K | Buy |
228
+8
| +4% | +$2.14K | ﹤0.01% | 325 |
|
|
2023
Q2 | $62.7K | Buy |
220
+20
| +10% | +$5.95K | ﹤0.01% | 303 |
|
|
2023
Q1 | $55.6K | Hold |
200
| – | – | ﹤0.01% | 304 |
|
|
2022
Q4 | $55.4K | Hold |
200
| – | – | ﹤0.01% | 293 |
|
|
2022
Q3 | $53K | Hold |
200
| – | – | ﹤0.01% | 288 |
|
|
2022
Q2 | $41K | Buy |
200
+184
| +1,150% | +$37.6K | ﹤0.01% | 310 |
|
|
2022
Q1 | $3K | Sell |
16
-7
| -30% | -$1.52K | ﹤0.01% | 624 |
|
|
2021
Q4 | $6K | Buy |
23
+18
| +360% | +$4.63K | ﹤0.01% | 527 |
|
|
2021
Q3 | $1K | Sell |
5
-10
| -67% | -$3.28K | ﹤0.01% | 665 |
|
|
2021
Q2 | $5K | Sell |
15
-1
| -6% | -$303 | ﹤0.01% | 509 |
|
|
2021
Q1 | $4K | Buy |
16
+4
| +33% | +$1.08K | ﹤0.01% | 495 |
|
|
2020
Q4 | $2K | Sell |
12
-2,270
| -99% | -$586K | ﹤0.01% | 397 |
|
|
2020
Q3 | $647K | Buy |
2,282
+440
| +24% | +$123K | 0.14% | 93 |
|
|
2020
Q2 | $493K | Buy |
1,842
+330
| +22% | +$99.2K | 0.12% | 98 |
|
|
2020
Q1 | $478K | Buy |
1,512
+289
| +24% | +$87.7K | 0.13% | 84 |
|
|
2019
Q4 | $363K | Buy |
1,223
+66
| +6% | +$18.3K | 0.12% | 89 |
|
|
2019
Q3 | $269K | Buy |
1,157
+88
| +8% | +$20.5K | 0.13% | 84 |
|
|
2019
Q2 | $250K | Buy |
1,069
+266
| +33% | +$61.4K | 0.15% | 82 |
|
|
2019
Q1 | $189K | Buy |
+803
| New | +$253K | 0.09% | 88 |
|
Other funds holding BIIB
Bogart Wealth's BIIB Position: Q3 2026 in Review
Bogart Wealth reduced its Biogen (BIIB) stake by 2.3% in Q3 2026, selling an estimated $1.06K and leaving 215 shares worth $48.6K. The position accounts for ﹤0.01% of the portfolio, ranked #565.
Bogart Wealth first reported a position in BIIB in Q1 2019 and has held it in 31 quarters since. The position peaked at $647K in Q3 2020. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Bogart Wealth held 215 shares of Biogen worth $48.6K as of Q3 2026.
- Bogart Wealth sold 5 Biogen shares in Q3 2026, an estimated $1.06K.
- Biogen made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #565 holding.
- Bogart Wealth first reported a position in Biogen in Q1 2019 and has held it in 31 quarters since.
- Bogart Wealth's Biogen position peaked at $647K in Q3 2020.
- 1,062 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.